Neonatal intestinal dysbiosis in necrotizing enterocolitis

Mol Med. 2018 Mar 15;24(1):4. doi: 10.1186/s10020-018-0002-0.

Abstract

Necrotizing Enterocolitis (NEC) is one of the most devastating gastrointestinal diseases in neonates, particularly among preterm infants in whom surgical NEC is the leading cause of morbidity. NEC pathophysiology occurs in the hyper-reactive milieu of the premature gut after bacterial colonization. The resultant activation of the TLR4 pathway appears to be a strongly contributing factor. Advancements in metagenomics may yield new clarity to the relationship between the neonatal intestinal microbiome and the development of NEC. After a century without effective directed treatments, microbiome manipulation offers a promising therapeutic target for the prevention and treatment of this devastating disease.

Keywords: Inflammation; Intestinal failure; Microbiome; Neonatal sepsis; Prematurity.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / therapeutic use
  • Dysbiosis* / chemically induced
  • Enterocolitis, Necrotizing* / immunology
  • Enterocolitis, Necrotizing* / microbiology
  • Gastrointestinal Microbiome*
  • Histamine H2 Antagonists / therapeutic use
  • Humans
  • Infant, Newborn
  • Toll-Like Receptors / immunology

Substances

  • Anti-Bacterial Agents
  • Histamine H2 Antagonists
  • Toll-Like Receptors